Support By : Li-lab
PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
---|---|---|---|---|---|
Parkinson's disease | R-HSA-1643685 | 0 | scriptaid | 4060 | drug-path |
Cardiac muscle contraction | R-HSA-397014 | map04260 | scriptaid | 4060 | drug-path |
Cytokine-cytokine receptor interaction | R-HSA-6788467 | map04060 | scriptaid | 4060 | drug-path |
Ribosome | R-HSA-5368277 | map03010 | scriptaid | 4060 | drug-path |
Cell adhesion molecules (CAMs) | R-HSA-1031690 | 0 | scriptaid | 4060 | drug-path |
Systemic lupus erythematosus | R-HSA-977105 | map05322 | scriptaid | 4060 | drug-path |
Pancreatic cancer | R-HSA-9700206 | map05212 | scriptaid | 4060 | drug-path |
Prostate cancer | R-HSA-2990872 | map05215 | scriptaid | 4060 | drug-path |
Apoptosis | R-HSA-109581 | map04210 | scriptaid | 4060 | drug-path |
ECM-receptor interaction | R-HSA-373711 | map04512 | scriptaid | 4060 | drug-path |
Small cell lung cancer | R-HSA-5619066 | map05222 | scriptaid | 4060 | drug-path |
Chronic myeloid leukemia | R-HSA-9680350 | map05220 | scriptaid | 4060 | drug-path |
Graft-versus-host disease | R-HSA-1643685 | map05332 | sulfinpyrazone | 5280863 | drug-path |
Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | sulfinpyrazone | 5280863 | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | sulfinpyrazone | 5280863 | drug-path |
Acute myeloid leukemia | R-HSA-9680350 | map05221 | sulfinpyrazone | 5280863 | drug-path |
Parkinson's disease | R-HSA-1643685 | 0 | sulfinpyrazone | 5280863 | drug-path |
Cell adhesion molecules (CAMs) | R-HSA-1031690 | 0 | sulfinpyrazone | 5280863 | drug-path |
Systemic lupus erythematosus | R-HSA-977105 | map05322 | sulfinpyrazone | 5280863 | drug-path |
Graft-versus-host disease | R-HSA-1643685 | map05332 | mebeverine | 4031 | drug-path |